Wealthcare Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Wealthcare Capital Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,979	Closed	-$210K	–	76
2023 Q2	$210K	Sell	8,979 -196	-2%	-$4.7K	0.02%	73
2023 Q1	$214K	Buy	9,175 +705	+8%	+$17.6K	0.03%	67
2022 Q4	$213K	Buy	+8,470	New	+$228K	0.03%	71
2022 Q2	–	Sell	-5,881	Closed	-$203K	–	72
2022 Q1	$203K	Buy	+5,881	New	+$208K	0.02%	77
2021 Q4	–	Sell	-5,513	Closed	-$280K	–	86
2021 Q3	$280K	Buy	5,513 +552	+11%	+$28.8K	0.03%	66
2021 Q2	$258K	Buy	4,961 +1,962	+65%	+$92.1K	0.02%	66
2021 Q1	$137K	Buy	+2,999	New	+$147K	0.01%	88

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wealthcare Capital Management's IDNA Position: Q3 2023 in Review

Wealthcare Capital Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2023, closing a stake of 8,979 shares — an estimated $210K sold.

Wealthcare Capital Management first reported a position in IDNA in Q1 2021 and held it in 7 quarters. The position peaked at $280K in Q3 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q3 2023.

Wealthcare Capital Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2023 after selling out during the quarter.
Wealthcare Capital Management sold 8,979 iShares Genomics Immunology and Healthcare ETF shares in Q3 2023, an estimated $210K.
Wealthcare Capital Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and held it in 7 quarters.
Wealthcare Capital Management's iShares Genomics Immunology and Healthcare ETF position peaked at $280K in Q3 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2023.

Based on Wealthcare Capital Management's 13F filing for Q3 2023, filed 12 Oct 2023.